[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2013, Vol. 11 ›› Issue (5): 327-336.doi: 10.3736/jintegrmed2013047

• Research Article • Previous Articles     Next Articles

Cardioprotection of Shenfu preparata on cardiac myocytes through cytochrome P450 2J3

Yong Xiaoa,b, Zeng-chun Maa, Yu-guang Wanga, Hong-ling Tana, Xiang-ling Tanga, Qian-de Lianga, Cheng-rong XiaoaYue Gaoa,b()   

  1. a. Beijing Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing 100850, China
    b. School of Pharmaceutical Sciences, Central South University, Changsha 410013, Hunan Province, China
  • Received:2013-05-24 Accepted:2013-07-18 Online:2013-09-10 Published:2013-09-15

Objective

To evaluate whether Shenfu injection (SFI) protects against cardiac myocyte injury induced by Fupian injection (FPI) in vitro.


Methods

H9c2 cells were separately treated with FPI, Renshen injection (RSI) and SFI. Cell viability, lactate dehydrogenase (LDH) release, spontaneous beating rate of primative cardical cells, caspase-3/7 activity, cell apoptosis, and cytochrome P450 2J3 (CYP2J3) mRNA expression were analyzed.


Results

The viability of H9c2 cells treated with SFI (37 and 75 mg/mL) was significantly higher than that of H9c2 cells treated with FPI (25 and 50 mg/mL) (P<0.05, P<0.01, respectively). LDH activity of H9c2 cells treated with SFI (75 mg/mL) was significantly decreased (P<0.01) compared with that of H9c2 cells treated with FPI (50 mg/mL). SFI (150 mg/mL) significantly attenuated FPI (100 mg/mL)-induced spontaneous beating rate decrease in primary myocardial cells after 4-hour treatment. Compared with FPI (12 and 25 mg/mL), SFI (18 and 37 mg/mL) treatment could effectively reverse the change of caspase-3/7 activity (P<0.01 and P<0.01, respectively). Compared with FPI (6 and 25 mg/mL), apoptotic cells decreased signi?cantly (P<0.05, P<0.01, respectively) when H9c2 cells were incubated with SFI (9 and 37 mg/mL). The expression of CYP2J3 mRNA was down-regulated by FPI, while RSI and SFI could up-regulate the expression of CYP2J3 (P<0.01), which suggested the potential mechanism of protection of RSI against cardiac myocyte damage induced by FPI treatment.


Conclusion

These observations indicate that SFI has the potential to exert cardioprotective effects against FPI toxicity. The effect was possibly correlated with the activation of CYP2J3.

Key words: Shenfu decoction, Cardiotonic agents, Cytochrome P450 2J3, Plant extracts, In vitro

Figure 1

The plant of Renshen and Fuzi and the chemical structures of its major extracts Renshen and Fuzi (A) are crude herbal drugs isolated from the dried root of rhizome of Panax ginseng C. A. Mey and Aconitum carmichaeli Debx., respectively. The Shenfu injection (B) manufactured by Ya’an Sanjiu Pharmaceutical Co., Ltd. (http://www.999.com/) has completed a phase II clinical trial in the USA (No. NCT00797953). Both Renshen injection and Fupian injection are the intermediate products of Shenfu injection, which is composed of Renshen injection and Fupian injection with a ratio of 1:2. One millimeter of Shenfu injection contains extracts of 0.1 g Renshen and 0.2 g Fupian. The chemical structures of the major components (ginsenoside Re, ginsenoside Rg1, ginsenoside Rb1 and ginsenoside Rg2) from Renshen and the major Fuzi extracts (benzoylhypaconitine and benzoyldeoxyaconitine) are shown in C and D, respectively."

"

Figure 2

The effects of SFI on H9c2 cell viability (Inverted fluorescence microscopy, ×100)The cells were treated with FPI, RSI and SFI at varied concentrations for 24 h, then the media were removed and the cells were incubated for 48 h in complete media before analyzing the media for stain with Zeiss Aviovert 200. A1: RSI 25 mg/mL; A2: RSI 50 mg/mL; A3: RSI 100 mg/mL; B1: FPI 25 mg/mL; B2: FPI 50 mg/mL; B3: FPI 100 mg/mL; C1: SFI 25 mg/mL; C2: SFI 50 mg/mL; C3: SFI 100 mg/mL. SFI: Shenfu injection; RSI: Renshen injection; FPI: Fupian injection."

Figure 3

The effects of SFI on cell viability in H9c2 cellsThe cells were treated with FPI, RSI and SFI at varied concentrations for 24 h, then the media were removed and cells were incubated for 48 h in complete media before analyzing the media cells viability. Data are expressed as mean ± standard deviation of three separate experiments. *P < 0.05, **P < 0.01, vs control; △P < 0.05, △△P < 0.01, vs FPI-treated cells. SFI: Shenfu injection; RSI: Renshen injection; FPI: Fupian injection."

Figure 4

The effects of SFI on LDH release in H9c2 cells The cells were treated with FPI, RSI and SFI at varied concentrations for 24 h, then the media were removed and cells were incubated for 48 h in complete media before analyzing the media for LDH release. Data are expressed as mean ± standard deviation of three separate experiments. *P < 0.05, **P < 0.01, vs control; △△P < 0.01, vs FPI-treated cells.SFI: Shenfu injection; RSI: Renshen injection; FPI: Fupian injection; LDH: lactate dehydrogenase."

Figure 5

The effects of SFI on the spontaneous beating rate in primary myocardial cellsData are expressed as mean ± standard deviation of three separate experiments. *P < 0.05, **P < 0.01, vs control; △P<0.05, vs FPI-treated cells. RSI: Renshen injection; FPI: Fupian injection; SFI: Shenfu injection."

Figure 6

The effects of SFI on level of caspase3/7 activityH9c2 cells were plated at the density of 5×104 /mL in 96-well white plates. Caspase-3/7 activity was measured with Acetyl-Asp-Glu-Val-Asp-7-amino-4-methylcoumarin (Ac-DEVD-CHO) as the substrate. A total of 100 μL of caspase-3/7 reagent was added to each well and further incubated in the dark for 1 h at room temperature, finally read with a ?uorescence spectrophotometer. Data are expressed as mean ± standard deviation of three separate experiments. *P < 0.05, **P < 0.01, vs control; △△P < 0.01, vs FPI-treated cells.SFI: Shenfu injection; RSI: Renshen injection; FPI: Fupian injection."

Figure 7

Apoptosis analysis of SFI on H9c2 cells by Annexin V-propidium iodide with flow cytometry methodH9c2 cells were pretreated with different concentrations of FPI, RSI and SFI for 24 h. Cells were harvested and apoptosis was confirmed by flow cytometry method (staining with both Annexin V-?uorescein isothiocyanatepropidium iodide) 6 h later. Data are expressed as mean ± standard deviation of three separate experiments. **P < 0.01, vs control; △P < 0.05, △△P <0.01, vs FPI-treated cells.SFI: Shenfu injection; RSI: Renshen injection; FPI: Fupian injection."

Figure 8

The effects of RSI (A), FPI (B), and SFI (C) on CYP2J3 mRNA expression in H9c2 cellsNormalization relative to GAPDH was performed. Levels of mRNA are expressed relative to control cardiomyoblast in the mean ± standard deviation values derived from three independent experiments. *P < 0.05, **P < 0.01, vs control.SFI: Shenfu injection; RSI: Renshen injection; FPI: Fupian injection; GAPDH: glyceraldehydes-3-phosphate dehydrogenase."

[1] Fu YK, Xie YM . Investigation of clinical practice and side effects of Shenfu injection[J]. Zhongguo Zhong Yao Za Zhi, 2012,37(18):2796-2799
[2] Xia ZY, Liu XY, Zhan LY, He YH, Luo T, Xia Z . Ginsenosides compound(shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart disease[J]. J Thorac Cardiovasc Surg, 2005,130(2):258-264
doi: 10.1016/j.jtcvs.2005.02.046
[3] Wang YL, Wang CY, Zhang BJ, Zhang ZZ . Shenfu injection suppresses apoptosis by regulation of Bcl-2 and caspase-3 during hypoxia/reoxygenation in neonatal rat cardiomyocytes in vitro[J]. Mol Biol Rep, 2007,36(2):365-370
[4] Song WT, Cheng FF, Xu L, Lin CR, Liu JX . Chinese medicine shenfu injection for heart failure: a systematic review and meta-analysis[J]. Evid Based Complement Alternat Med, 2012,2012:713149
[5] Wang SD, Yuan L, Jiang Y, Li XQ, Wang XZ . Myocardial protective effect of Shenfu injection in patients undergoing valve replacement[J]. Zhonghua Yi Xue Za Zhi, 2007,87(33):2316-2319
[6] Li ZE . Clinical research on effects of shenfu injection in different dosage in preventing heart failure occurred in patients of acute myocardial infarction with elevated ST segment[J]. Zhongguo Zhong Xi Yi Jie He Za Zhi, 2006,26(6):555-557
[7] Zheng CD, Min S . Cardioprotection of Shenfu Injection against myocardial ischemia/reperfusion injury in open heart surgery[J]. Chin J Integr Med, 2008,14(1):10-16
doi: 10.1007/s11655-008-0010-y
[8] Li Q, Li BZ, Liu H . Pharmacological action and clinical application of Shen Fu injection[J]. Yi Xue Zong Shu, 2008,14(8):1247-1250
[9] Xu J, Lou HG, Lou YJ, He W, Xu X, Xu DH . Research advance in pharmacological action of “Shenfu Injection”[J]. Shanghai Zhong Yi Yao Za Zhi, 2008,42(10):87-89
[10] Wu Y, Xia ZY, Meng QT, Zhu J, Lei S, Xu J, Dou J . Shen-Fu injection preconditioning inhibits myocardial ischemia-reperfusion injury in diabetic rats: activation of eNOS via the PI3K/Akt pathway[J]. J Biomed Biotechnol, 2011,2011:384627
[11] Yang RJ, Li XW, Zhang PX, Yao H, Yu AM, Zhao XZ, Jin YR . Determination of four kinds of monoester-diterpenoid aconines in SHEN-FU injection by homogeneous ionic liquid microextraction-high performance liquid chromatography[J]. Gao Deng Xue Xiao Hua Xue Xue Bao, 2011,32(12):2752-2756
[12] Yang RJ, Li XW, Yao H, Zhang MC, Jin YR . Determination of ten rare ginsenosides in three kinds of injection by solid-phase extraction high-performance liquid chromatography[J]. Chromatographia, 2012,75(5-6):281-287
doi: 10.1007/s10337-012-2183-y
[13] Zhang F, Tang MH, Chen LJ, Li R, Wang XH, Duan JG, Zhao X, Wei YQ . Simultaneous quantitation of aconitine, mesaconitine, hypaconitine, benzoylaconine, benzoylmesaconine and benzoylhypaconine in human plasma by liquid chromatography-tandem mass spectrometry and pharmacokinetics evaluation of “SHEN-FU” injectable powder[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2008,873(2):173-179
doi: 10.1016/j.jchromb.2008.08.008
[14] Liou SS, Liu IM, Lai MC, Cheng JT . Comparison of the antinociceptive action of crude Fuzei, the root of Aconitum, and its processed products[J]. J Ethnopharmacol, 2005,99(3):379-383
doi: 10.1016/j.jep.2005.02.014
[15] Shim SH, Kim JS, Kang SS . Norditerpenoid alkaloids from the processed tubers of Aconitum carmichaeli[J]. Chem Pharm Bull (Tokyo), 2003,51(8):999-1002
doi: 10.1248/cpb.51.999
[16] Ma ZC, Zhou SS, Liang QD, Huo C, Wang YG, Tan HL, Xiao CR, Gao Y . UPLC-TOF/MS based chemical profiling approach to evaluate toxicity-attenuated chemical composition in combination of ginseng and radix aconiti praeparata[J]. Yao Xue Xue Bao, 2011,46(12):1488-1492
[17] Singhuber J, Zhu M, Prinz S, Kopp B . Aconitum in traditional Chinese medicine: a valuable drug or an unpredictable risk?[J] Ethnopharmacol. 2009; 126(1):18-30.
doi: 10.1016/j.jep.2009.07.031
[18] Chan TY . Aconite poisoning[J]. Clin Toxicol, 2009,47(4):279-285
doi: 10.1080/15563650902904407
[19] Elbekai RH, El-Kadi AO . Cytochrome P450 enzymes: central players in cardiovascular health and disease[J]. Pharmacol Ther, 2006,112(2):564-587
doi: 10.1016/j.pharmthera.2005.05.011
[20] Alsaad AM, Zordoky BN, El-Sherbeni AA, El-Kadi AO . Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats[J]. Drug Metab Dispos, 2012,40(11):2126-2135
doi: 10.1124/dmd.112.046631
[21] Wang B, Shravah J, Luo H, Raedschelders K, Chen DD, Ansley DM . Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation[J]. Biochem Biophys Res Commun, 2009,389(1):105-111
doi: 10.1016/j.bbrc.2009.08.097
[22] Yang T, Zhu T, Zhou H, Lin QL, Li WJ, Liu JW . Rice protein hydrolysate attenuates hydrogen peroxide induced apoptosis of myocardiocytes H9c2 through the Bcl-2/Bax pathway[J]. Food Res Int, 2012,48(2):736-741
doi: 10.1016/j.foodres.2012.06.017
[23] Wang Q, Jin J, Guo Z, Chen F, Qiu Y, Zhu J, Shang Y . Improvements in the primary culture of neonate rat myocardial cells by study of the mechanism of endoplasmic reticulum stress[J]. Cell Stress Chaperones, 2013,18(3):367-375
doi: 10.1007/s12192-012-0390-y
[24] Nie XJ, Zhao XP, Wang Y . Development of fluorescence imaging-based system for screening compounds with antitumor activity[J]. Zhejiang Da Xue Xue Bao Yi Xue Ban, 2011,40(6):617-621, 646
[25] Jindal E, Goswami SK . In cardiac myoblasts, cellular redox regulates FosB and Fra-1 through multiple cis-regulatory modules[J]. Free Radic Biol Med, 2011,51(8):1512-1521
doi: 10.1016/j.freeradbiomed.2011.07.008
[26] Wang M, Sun GB, Sun X, Wang HW, Meng XB, Qin M, Sun J, Luo Y, Sun XB . Cardioprotective effect of salvianolic acid B against arsenic trioxide-induced injury in cardiac H9c2 cells via the PI3K/Akt signal pathway[J]. Toxicol Lett, 2013,216(2-3):100-107
doi: 10.1016/j.toxlet.2012.11.023
[27] Hosseinzadeh L, Behravan J, Mosaffa F, Bahrami G, Bahrami A, Karimi G . Curcumin potentiates doxorubicin-induced apoptosis in H9c2 cardiac muscle cells through generation of reactive oxygen species[J]. Food Chem Toxicol, 2011,49(5):1102-1109
doi: 10.1016/j.fct.2011.01.021
[28] Patruno A, Franceschelli S, Pesce M, Maccallini C, Fantacuzzi M, Speranza L, Ferrone A, De Lutiis MA, Ricciotti E, Amoroso R, Felaco M . Novel aminobenzyl-acetamidine derivative modulate the differential regulation of NOSs in LPS induced inflammatory response: role of PI3K/Akt pathway[J]. Biochim Biophys Acta, 2012,1820(12):2095-2104
doi: 10.1016/j.bbagen.2012.08.014
[29] Deng Y, Theken KN, Lee CR . Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation[J]. J Mol Cell Cardiol, 2010,48(2):331-341
doi: 10.1016/j.yjmcc.2009.10.022
[30] Xu X, Zhang XA, Wang DW . The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases[J]. Adv Drug Deliv Rev, 2011,63(8):597-609
doi: 10.1016/j.addr.2011.03.006
[31] Fradette C, Du Souich P . Effect of hypoxia on cytochrome P450 activity and expression[J]. Curr Drug Metab, 2004,5(3):257-271
doi: 10.2174/1389200043335577
[32] Zordoky BN, El-Kadi AO . Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure[J]. Curr Drug Metab, 2008,9(2):122-128
doi: 10.2174/138920008783571792
[33] Wang HX, Zhang DM, Zeng XJ, Mu J, Yang H, Lu LQ, Zhang LK . Upregulation of cytochrome P450 2J3/11,12-epoxyeicosatrienoic acid inhibits apoptosis in neonatal rat cardiomyocytes by a caspase-dependent pathway[J]. Cytokine, 2012,60(2):360-368
doi: 10.1016/j.cyto.2012.04.029
[34] Kuo YH, Lin YL, Don MJ, Chen RM, Ueng YF . Induction of cytochrome P450-dependent monooxygenase by extracts of the medicinal herb Salvia miltiorrhiza[J]. J Pharm Pharmacol, 2006,58(4):521-527
doi: 10.1211/jpp.58.4.0012
[35] Gross GJ, Falck JR, Gross ER, Isbell M, Moore J, Nithipatikom K . Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited[J]. Cardiovasc Res, 2005,68(1):18-25
doi: 10.1016/j.cardiores.2005.06.007
[36] Zordoky BN, El-Kadi AO . Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells[J]. Vascul Pharmacol, 2008,49(4-6):166-172
doi: 10.1016/j.vph.2008.07.004
[37] Delozier TC, Kissling GE, Coulter SJ, Dai D, Foley JF, Bradbury JA, Murphy E, Steenbergen C, Zeldin DC, Goldstein JA . Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues[J]. Drug Metab Dispos, 2007,35(4):682-688
doi: 10.1124/dmd.106.012823
[38] Xia ZY, Zhan LY, He YH, Liu XY . The effect of Shen-Fu on gastrointestinal tract injury and its potential mechanism during cardio-pulmonary bypass in patients undergoing cardiac surgery[J]. Chin J Traumatol, 2003,6(4):245-248
[39] Luo J, Min S, Wei K, Cao J . Ion channel mechanism and ingredient bases of Shenfu Decoction’s cardiac electrophysiological effects[J]. J Ethnopharmacol, 2008,117(3):439-445
doi: 10.1016/j.jep.2008.02.022
[1] Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384.
[2] Keat Lam Ho, Phaik Har Yong, Chee Woon Wang, Umah Rani Kuppusamy, Chek Tung Ngo, Festo Massawe, Zhi Xiang Ng. Peperomia pellucida (L.) Kunth and eye diseases: A review on phytochemistry, pharmacology and toxicology. Journal of Integrative Medicine, 2022, 20(4): 292-304.
[3] Lu Yin, Yun An, Xiao Chen, Hui-xin Yan, Tao Zhang, Xin-gang Lu, Jun-tao Yan. Local vibration therapy promotes the recovery of nerve function in rats with sciatic nerve injury. Journal of Integrative Medicine, 2022, 20(3): 265-273.
[4] Zeinab Vafaeipour, Bibi Marjan Razavi, Hossein Hosseinzadeh. Effects of turmeric (Curcuma longa) and its constituent (curcumin) on the metabolic syndrome: An updated review. Journal of Integrative Medicine, 2022, 20(3): 193-203.
[5] Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192.
[6] Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212.
[7] Jia-yi Zhao, Jin Pu, Jian Fan, Xin-yu Feng, Jian-wen Xu, Rong Zhang, Yan Shang. Tanshinone IIA prevents acute lung injury by regulating macrophage polarization. Journal of Integrative Medicine, 2022, 20(3): 274-280.
[8] Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134.
[9] Peter Bablis, Henry Pollard, Anthony L. Rosner. Stress reduction via neuro-emotional technique to achieve the simultaneous resolution of chronic low back pain with multiple inflammatory and biobehavioural indicators: A randomized, double-blinded, placebo-controlled trial. Journal of Integrative Medicine, 2022, 20(2): 135-144.
[10] Jose Antonio Castilla-Jimena, Isabel Ruiz-Pérez, Jesús Henares-Montiel. Impact of socioeconomic and health-related factors on consumption of homeopathic and natural remedies in Spain in 2006, 2011 and 2017. Journal of Integrative Medicine, 2022, 20(1): 52-56.
[11] Jun-peng Yao, Li-ping Chen, Xian-jun Xiao, Ting-hui Hou, Si-yuan Zhou, Ming-min Xu, Kai Wang, Yu-jun Hou, Lin Zhang, Ying Li. Effectiveness and safety of acupuncture for treating functional constipation: An overview of systematic reviews. Journal of Integrative Medicine, 2022, 20(1): 13-25.
[12] Ofer Baranovitch, Meirav Wolff-Bar, Meora Feinmesser, Chen Sade-Zaltz, Ilan Tsarfaty, Victoria Neiman. Searching for the emotional roots of breast cancer: A cross-disciplinary analysis integrating psychology, Chinese medicine, and oncology biomarkers. Journal of Integrative Medicine, 2022, 20(1): 57-64.
[13] Deng-chao Wang, Miao Yu, Wen-xian Xie, Li-yan Huang, Jian Wei, Yue-hua Lei. Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019. Journal of Integrative Medicine, 2022, 20(1): 26-33.
[14] Miriam Bazzicalupo, Laura Cornara, Bruno Burlando, Alberta Cascini, Marcella Denaro, Antonella Smeriglio, Domenico Trombetta. Carpobrotus edulis (L.) N.E.Br. extract as a skin preserving agent: from traditional medicine to scientific validation. Journal of Integrative Medicine, 2021, 19(6): 526-536.
[15] Meng-ya Shan, Ying Dai, Xiao-dan Ren, Jing Zheng, Ke-bin Zhang, Bin Chen, Jun Yan, Zi-hui Xu. Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis. Journal of Integrative Medicine, 2021, 19(6): 545-554.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-rong Fu. Establishment of multivariate diagnosis and treatment system of modern gynecology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 22-24
[2] Hao Li, Ming-jiang Yao, Wen-ming Zhao, Jie Guan, Lin-lin Cai, Ling Cui. A randomized, controlled, double-blind trial of Huannao Yicong capsule in senile patients with mild cognitive impairment. Journal of Chinese Integrative Medicine, 2008, 6(1): 25-31
[3] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[4] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[5] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[6] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100
[9] Gui Yu, Jie Wang. Thinking on building the network cardiovasology of Chinese medicine. Journal of Chinese Integrative Medicine, 2012, 10(11): 1206-1210
[10] Pedro Saganha João, Doenitz Christoph, Greten Tobias, Efferth Thomas, J. Greten Henry. Qigong therapy for physiotherapists suffering from burnout: a preliminary study. Journal of Chinese Integrative Medicine, 2012, 10(11): 1233-1239
[an error occurred while processing this directive]